MACE Up for High-Risk Patients After Noncardiac Surgery
Incidence of MACE 20.6% within 365 days in patients at increased CV risk.
Surgery
COVID-19-Free Surgical Pathways May Aid Cancer Surgery Outcomes
Pulmonary complication, postoperative SARS-CoV-2 infection rates lower with COVID-19-free pathways.
Investigators ID Predictors of CKD Progression After Radical Nephrectomy
Kidney microstructural features appear predictive of progressive CKD and mortality following radical nephrectomy.
Doubling of Radical Surgery Rates for High-Risk Prostate Cancer Reported
By 2016, radical prostatectomy use nearly equaled radiation therapy use for high-risk prostate cancer.
Metastasectomy Survival Benefit in mRCC Cases Confirmed
New data show that complete metastasectomy for selected cases of metastatic renal cell carcinoma (mRCC) prolongs survival in the postcytokine therapy era.
PN Risks May Outweigh Benefits in Some CKD Cases
Investigators highlight the importance of preoperative renal biopsy to rule out an indolent or benign tumor in patients with stage 4 CKD.
Complete Metastasectomy Found to Prolong Survival in mRCC
A study showed that mortality risk was reduced by 59% for patients who underwent complete metastasectomy compared with those who did not.
Bariatric Surgery Linked to Reduction in Mortality Rate
And RYGB is effective for blood pressure control in patients with hypertension and obesity.
Thorough Risk Assessment Essential Prior to Noncardiac Surgery
Review shows history, exam necessary to reduce perioperative cardiovascular complications.
Prioritizing Urologic Cancer Cases During the COVID-19 Pandemic
Investigators performed a literature review to better understand how delays in treatment might affect clinical outcomes in urologic cancer patients, including the risk of upstaging, recurrence, and mortality.
-
Loading...
-
Loading...
Next post in Upper tract urothelial carcinoma
